AMAG Pharmaceuticals Accounts Payable

AMAG Pharmaceuticals (AMAG) currently reports a accounts payable of $9.7M as of September 2020. That compares with $27M in the prior-year period — down 63.3% year over year. Use the charts on this page to explore AMAG Pharmaceuticals's accounts payable history and peer comparisons.

AMAG Pharmaceuticals's accounts payable decreased from $27M to $9.7M — a 63.3% year-over-year decrease (period ending September 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AMAG Pharmaceuticals reported $9.7M in accounts payable as of September 2020. That compares with $27M in the prior-year period — down 63.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $9.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AMAG Pharmaceuticals, and consider following AMAG for alerts when major investors trade the stock.

AMAG Pharmaceuticals is classified in the Healthcare sector. On accounts payable, it currently shows $9.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AMAG with unrelated industries.